Literature DB >> 10058

Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.

C Erzin-Waters, P Muller, P Seeman.   

Abstract

To investigate the extent of cholinergic involvement in opiate-induced catalepsy, the effects of three anticholinergic drugs were studied on morphine-induced catalepsy. Haloperidol-induced catalepsy was also examined. Maximum catalepsy in rats was obtained with 30 mg/kg morphine or 3 mg/kg haloperidol. The anticholinergic drugs atropine, benztropine, and scopolamine were unable to antagonize morphine-induced catalepsy, yet readily antagonized haloperidol-induced catalepsy. Low doses of apomorphine (7.5 mg/kg), on the other hand, readily antagonized morphine catalepsy, but 13-fold higher doses of apomorphine were needed to block haloperidol-induced catalepsy. The results are compatible with the idea that catalepsy can be mediated via the striatum or the amygdala; morphine-dopamine antagonism may occur in the amygdala, whereas morphine-dopamine-cholinergic interactions occur in the striatum.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10058     DOI: 10.1139/y76-071

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  15 in total

1.  Is morphine-induced catalepsy related to activation of dopaminergic neurones?

Authors:  P Moleman; D J Versluis; J Bruinvels
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

2.  Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.

Authors:  Darryl T Hamamoto; Subhalakshmi Giridharagopalan; Donald A Simone
Journal:  Eur J Pharmacol       Date:  2006-12-09       Impact factor: 4.432

Review 3.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

4.  Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics.

Authors:  A S Undie; E Friedman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Experimental catalepsy: influences of cholinergic transmission in restraint-induced catalepsy.

Authors:  W R Klemm
Journal:  Experientia       Date:  1983-02-15

6.  Altered pilocarpine- or chlorpromazine-induced catalepsy after long-term treatment with cholinergic drugs.

Authors:  G Gianutsos
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

7.  Effect of morphine on dopaminergic neurons in the rat basal forebrain and striatum.

Authors:  P Moleman; J Bruinvels
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

8.  Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.

Authors:  S Chiu; R K Mishra
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

9.  Cholinergic-dopaminergic interactions in experimental catalepsy.

Authors:  W R Klemm
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.

Authors:  W R Prescott; L H Gold; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.